A phase II study of temozolomide and bevacizumab in patients with advanced neuroendocrine tumorsMatthew H. Kulke, Charles S. Fuchs, Jeffrey W. Clark et al.|Journal of Clinical Oncology|2006Cited by 92
Asymptomatic carriage of extensively drug-resistant bacteria (eXDR), a simple way to assess spontaneous clearanceÉric Farfour, J.‐C. Séguier, Anis Larbi et al.|Journal of Hospital Infection|2019Cited by 7